This inventor holds 2 USPTO granted patents. Top assignee: Gist-Brocades N.v.. Active years: 1992-1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- AE Berkel En Rodenrijs, NL (1992)
- Berkel En Rodenrijs, NL (1994)
Company Filing History:
Years Active: 1992-1994
Title: Harmen Slijkhuis: Innovator in Steroid Synthesis
Introduction
Harmen Slijkhuis is a notable inventor based in Berkel en Rodenrijs, Netherlands. He has made significant contributions to the field of steroid synthesis, particularly through his innovative methods involving Mycobacterium species. With a total of 2 patents, his work has implications for the development of therapeutically important steroids.
Latest Patents
Slijkhuis's latest patents focus on the preparation of 9-alpha-hydroxy-17-keto steroids. These steroids are produced by fermenting steroids that have a C-17-side chain of 5-10 carbon atoms with the novel Mycobacterium species CBS 482.86. The process yields compounds such as 9-alpha-hydroxyandrost-4-ene-3,17-dione and 7-alpha,9-alpha,12-alpha-trihydroxyandrost-4-ene-3,17-dione in high yield. These resulting compounds serve as useful intermediates in the synthesis of corticosteroids, which are therapeutically significant.
Career Highlights
Harmen Slijkhuis has been associated with Gist-Brocades N.V., where he has applied his expertise in microbiological processes to advance steroid synthesis. His innovative approaches have positioned him as a key figure in the field, contributing to advancements that benefit pharmaceutical applications.
Collaborations
One of his notable collaborators is Arthur F Marx, with whom he has worked on various projects related to steroid synthesis. Their combined efforts have led to significant advancements in the field.
Conclusion
Harmen Slijkhuis is a distinguished inventor whose work in steroid synthesis has paved the way for important therapeutic developments. His innovative methods and collaborations continue to influence the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile